Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-18-009401
Filing Date
2018-08-20
Accepted
2018-08-20 16:06:25
Documents
55
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT nulf_10q.htm 10-Q 600874
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF nulf_ex311.htm EX-31.1 16794
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE nulf_ex321.htm EX-32.1 9746
  Complete submission text file 0001654954-18-009401.txt   2551498

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT nulf-20180630.xml EX-101.INS 359974
5 XBRL TAXONOMY EXTENSION SCHEMA nulf-20180630.xsd EX-101.SCH 32918
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nulf-20180630_cal.xml EX-101.CAL 36158
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nulf-20180630_def.xml EX-101.DEF 102654
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nulf-20180630_lab.xml EX-101.LAB 182648
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nulf-20180630_pre.xml EX-101.PRE 169760
Mailing Address 2618 SAN MIGUEL SUITE 203 SAN CLEMENTE CA 92660
Business Address 2618 SAN MIGUEL SUITE 203 SAN CLEMENTE CA 92660 949-973-0684
NuLife Sciences, Inc. (Filer) CIK: 0001592603 (see all company filings)

EIN.: 463876675 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-55805 | Film No.: 181028322
SIC: 2834 Pharmaceutical Preparations